Source: Annual Congress 2013 –Structural and functional imaging discussion: sometimes different but always linked



Rating:

Share or cite this content

Citations should be made in the following way:
A. Kalkanis, D. Kalkanis, D. Drougas, N. Karagiannidis, M. Panagiotou, D. Exarhos, I. Datseris, V. Polychronopoulos (Athens, Maroussi, Greece). 18F-FDG PET scans demonstrate strong correlation between spleen metabolism and serum IL-2R levels in patients with untreated sarcoidosis under surveillance. Eur Respir J 2013; 42: Suppl. 57, 236

Member's Comments

No comment yet.

Related content which might interest you: Strong correlation between 18F-FDG PET positive bone involvement and increased IL-2R levels in patients with untreated sarcoidosis under surveillance (Preliminary results) Source: Annual Congress 2012 - Cystic lung diseases: lung granulomatosis Year: 2012 The surveillance of recurred/refractory lung malignancy using whole-body MRI: Correlation with the results assessed by PET-CT Source: Annual Congress 2010 - Staging of lung cancer Year: 2010 The role of 18-FDG PET/CT in lung sarcoidosis Source: International Congress 2017 – The many faces of sarcoidosis Year: 2017 Does positron emission tomography (PET/CT) have a role to play in the management of patients presenting with pleural changes suggestive of malignancy Source: Annual Congress 2009 - Diagnosis and management of pleural effusions and mesothelioma: improving old techniques and new tools Year: 2009 Increased FDG uptake on 18F-FDG PET/CT in residual lesions of tuberculosis Source: International Congress 2019 – Tuberculosis: from diagnosis to complications Year: 2019 Changes in pulmonary 18F-FDG SUVmax reflect treatment response in patients with diffuse parenchymal lung disease; a PET/CT proof of concept study Source: Annual Congress 2010 - Different patterns of diffuse parenchymal lung disease Year: 2010 An 8 year- review of granulomatous inflammation in EBUS samples- common in sarcoidosis, rare but identified in the setting of cancer where FDG uptake can be observed on PET scanning. Source: International Congress 2018 – Lung cancer: new tools for diagnosis and patient assessment Year: 2018 Comparison of CT and PET in detection of lung metastases Source: Annual Congress 2004 - Lung cancer: epidemiology, diagnosis, staging Year: 2004 CT and FDG PET/CT findings of pulmonary involvement in methotrexate-associated lymphoproliferative disease Source: International Congress 2018 – CC6 Interstitial lung diseases Year: 2018 Correlation between standardised uptake value on PET scans, tumour characteristics and survival in resected lung cancer patients Source: Annual Congress 2007 - Prognosis and diagnosis of thoracic malignancies Year: 2007 Management of bone metastases (BM): results of a large multinational, multidisciplinary survey Source: Annual Congress 2005 - Management of lung cancer: clinical problems Year: 2005 Solitary pulmonary nodules on PET scans – follow up strategy and outcome of low uptake nodules Source: Eur Respir J 2005; 26: Suppl. 49, 313s Year: 2005 Radiologic and clinical outcomes of small pulmonary nodules detected on low-dose computed tomography Source: Annual Congress 2005 - Screening and imaging of lung cancer Year: 2005 Comparison of chest x-ray, thoracic computed tomography and 18F-FDG PET/CT for staging of sarcoidosis Source: International Congress 2015 – Sarcoidosis: clinical Year: 2015 Two patients with a nodular lung pattern Source: Annual Congress 2007 - Radiology Grand Round: an interactive session Year: 2007 PD-L1 expression correlation with metabolic parameters of 18F FDG PET/CT in nonsmall cell lung cancer> Source: Virtual Congress 2021 – Pulmonary neoplasia and related pathologies Year: 2021 18F-fluorodeoxyglucose (18FDG) PET pulmonary imaging:comparative methodology in COPD patients Source: International Congress 2014 – COPD and PAH related imaging Year: 2014 Detection of extrapulmonary lesions with integrated PET/CT in the staging of lung cancer Source: Eur Respir J 2007; 29: 995-1002 Year: 2007 In vivo assessment of lung inflammatory cell activity in patients with COPD and asthma Source: Eur Respir J 2003; 21: 567-573 Year: 2003 Imaging of sarcoidosis of the airways and lung parenchyma and correlation with lung function}, Source: Eur Respir J 2012; 40: 750-765 Year: 2012